{
  "trial_id": "NCT01717911",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Recently diagnosed type 2 diabetic patients.",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "Fasting plasma glucose between 200-300 mg/dl (A1C level between 7% and 10%).",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Those who age between 30 and 80 years old and can inject insulin by themselves.",
      "label": "met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous treated with anti-diabetic medication",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant or nursing women.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Impaired liver function (ALT > 120 U/L)",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Impaired renal function (Serum creatinine >1.5 mg/dL in male, >1.4 mg/dL in female )",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Recently suffered from MI or CVA.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients are acute intercurrent illness.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "2-hour C-peptide level < 1.8 ng/mL.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has type 1 diabetes, not type 2. He is being treated with ACE inhibitors and Beta blockers for cardiomyopathy.",
  "_meta": {
    "topic_id": "65",
    "trial_id": "NCT01717911",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}